© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
October 23, 2020
The findings of this multicenter cohort may have implications for diagnosis, prognosis, and disease monitoring, as well as for clinical trials targeting disease-specific proteins in DLB.
October 17, 2020
A younger baseline age and more injections during the first year of treatment was linked to better long-term outcomes.
October 16, 2020
Venetoclax in combination with azacitidine was shown to prolong survival and increase chance of remission.
October 11, 2020
Cataracts, but not AMD or glaucoma, were associated with an increased risk of depressive symptoms in the elderly in a prospective long-term study.
October 09, 2020
ELP Pharma readying plans to continue to study the drug in a phase 3 trial.
October 03, 2020
History of syncope was present in 17% of the Parkinson group who had an altered blood pressure regulation upon standing and in 10% of those without.
October 01, 2020
SFChT in treatment-naïve eyes was positively associated with eGFR and diabetic retinopathy grade.
September 25, 2020
The treatment could also be used for Alzheimer disease and mid-stage Huntington disease for patients who suffer from greater cognitive deficits.
September 22, 2020
Those who slept more than 10 hours or less than 4 hours per night declined faster than those who slept about 7 hours per night.
September 19, 2020
Sumifilam could be the first Alzheimer treatment to improve several biomarkers.